Vaccine-educated T cells and a CD123 bispecific T-cell engager for treatment of acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Vaccine-educated T cells and a CD123 bispecific T-cell engager for treatment of acute myeloid leukemia.
Authors: Liegel J; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Stroopinsky D; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Cheloni G; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Karagkouni D; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Nahas M; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Ma Y; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Torres D; Beth Israel Deaconess Medical Center, Boston, MA., Saldarriaga I; Beth Israel Deaconess Medical Center, Boston, MA., Wang S; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Spatial Technologies Unit, Beth Israel Deaconess Medical Center, Boston, MA., Arruda de Amaral A; Beth Israel Deaconess Medical Center, Boston, MA.; Spatial Technologies Unit, Beth Israel Deaconess Medical Center, Boston, MA., Ploumakis A; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Spatial Technologies Unit, Beth Israel Deaconess Medical Center, Boston, MA., Clohessy J; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Abirached J; Beth Israel Deaconess Medical Center, Boston, MA., Bisharat L; Beth Israel Deaconess Medical Center, Boston, MA., Fraenkel P; Sanofi, Cambridge, MA., Yildirim O; Sanofi, Cambridge, MA., Bonnevaux H; Sanofi, Paris, France., Guerif S; Sanofi, Paris, France., Rallis K; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Chedid G; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Kufe D; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Vlachos IS; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Spatial Technologies Unit, Beth Israel Deaconess Medical Center, Boston, MA., Avigan D; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Rosenblatt J; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Source: Blood advances [Blood Adv] 2025 Nov 11; Vol. 9 (21), pp. 5585-5597.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2024015449